recent
studi
suggest
associ
interferon
induc
transmembran
variant
cours
influenza
infect
howev
clear
whether
report
associ
relat
influenza
infect
sever
aim
studi
estim
hospit
risk
associ
variant
influenza
like
ill
ili
patient
pandem
influenza
casecontrol
genet
associ
studi
perform
use
nasopharyngealoropharyng
swab
collect
pandem
influenza
laboratori
diagnosi
influenza
infect
perform
rtpcr
genotyp
rflp
test
associ
hospit
condit
logist
regress
perform
calcul
confounderadjust
odd
ratio
hospit
associ
select
ili
case
match
nonhospit
control
within
ili
influenza
posit
patient
statist
signific
associ
found
variant
hospit
risk
adjust
ci
regard
ili
influenza
neg
patient
ctcc
genotyp
carrier
higher
risk
hospit
patient
tt
genotyp
adjust
ci
variant
associ
respiratori
infect
hospit
specif
patient
infect
influenza
influenza
contagi
debilit
diseas
respiratori
tract
lead
hospit
even
death
remain
public
health
threat
april
outbreak
influenza
infect
detect
mexico
subsequ
case
observ
mani
countri
includ
portug
spread
quickli
throughout
world
caus
least
death
less
year
unlik
diseas
pattern
observ
epidem
season
influenza
mani
sever
case
influenza
viru
infect
observ
healthi
young
peopl
approxim
death
due
influenza
occur
younger
year
peopl
infect
influenza
viru
experienc
mild
diseas
upper
respiratori
ill
similar
season
influenza
viru
infect
contrast
gastrointestin
symptom
occur
frequent
patient
infect
pandem
influenza
viru
season
influenza
accord
portugues
influenza
surveil
program
nisp
laboratoryconfirm
case
influenza
viru
detect
age
group
year
old
total
hospit
report
estim
mortal
rate
per
inhabit
correspond
laboratori
confirm
influenza
death
commonli
accept
sever
influenza
infect
result
complex
interplay
host
pathogen
factor
mani
gap
basic
understand
influenc
ill
sever
mainli
among
peopl
without
known
comorbid
individu
resist
infect
recov
quickli
other
experi
sever
diseas
associ
infect
intens
research
perform
virul
viru
includ
genom
variabl
littl
known
host
genet
background
influenc
influenza
outcom
despit
crucial
impact
immun
respons
cours
infect
consequ
world
health
organ
identifi
studi
host
genet
factor
role
suscept
sever
influenza
prioriti
although
characterist
age
comorbid
degre
preexist
immun
immunosupress
pregnanc
smoke
influenc
acquisit
progress
resolut
influenza
infect
genet
variant
found
human
popul
affect
specif
viru
bind
subsequ
effect
immun
respons
import
human
alreadi
shown
sever
bacteri
viral
pathogen
current
known
infecti
diseas
lethal
herit
compon
addit
anim
model
seem
support
biolog
plausibl
genet
suscept
influenza
viru
given
mous
strain
suscept
influenza
viru
infect
sever
independ
viru
subtyp
suggest
common
infect
pathway
shown
interferon
induc
transmembran
protein
act
viral
restrict
factor
mediat
cellular
resist
sever
virus
block
earli
stage
viral
replic
profoundli
alter
cours
influenza
viru
infect
knockout
mous
model
mice
lack
function
gene
develop
sever
viral
pneumonia
challeng
normal
low
pathogen
virus
protect
reestablish
reintroduct
human
overrepresent
individu
variant
c
allel
alter
splice
acceptor
site
found
european
patient
requir
hospit
result
influenza
infect
recent
studi
suggest
close
associ
variant
c
allel
influenza
sever
infect
specif
metaanalysi
includ
previous
refer
studi
suggest
signific
associ
variant
c
allel
sever
influenza
suscept
mild
influenza
subject
uk
caucasian
han
chines
popul
conclud
c
allel
constitut
risk
factor
sever
influenza
infect
case
consid
wider
confid
interv
small
sampl
size
heterogen
inclus
criteria
previou
studi
main
object
present
studi
estim
associ
variant
c
allel
risk
hospit
due
respiratori
ill
portugues
patient
influenza
infect
use
appropri
design
epidemiolog
studi
casecontrol
genet
associ
studi
compar
frequenc
variant
hospit
influenzalik
ill
ili
patient
case
non
hospit
ili
patient
control
perform
biolog
sampl
case
control
consist
nasopharyngealoropharyng
swab
receiv
portugues
nation
influenza
refer
laboratori
nation
health
institut
doctor
ricardo
jorg
insa
diagnost
purpos
pandem
portugues
laboratori
network
diagnosi
influenza
infect
septemb
februari
insa
coordin
network
respons
carri
laboratori
diagnosi
influenza
infect
request
nation
health
servic
pandem
network
receiv
swab
ili
patient
identifi
primari
healthcar
unit
hospit
inform
collect
regard
clinic
epidemiolog
inform
patient
demograph
data
sign
symptom
underli
condit
laboratori
result
store
nation
common
databas
total
ili
case
report
laboratori
network
pandem
laboratoryconfirm
influenza
case
associ
new
pandem
strain
insa
sampl
influenza
diagnosi
receiv
influenza
posit
case
identifi
ili
posit
patient
defin
patient
present
sign
symptom
compli
european
ili
case
definit
swab
test
posit
influenza
use
realtim
polymeras
chain
reaction
rtpcr
ili
neg
patient
ili
patient
swab
test
neg
influenza
viru
ili
patient
test
neg
influenza
viru
also
test
neg
influenza
b
viru
subtyp
includ
patient
select
insa
case
whose
test
influenza
diagnosi
perform
nation
influenza
refer
laboratori
insa
follow
exclus
criteria
use
perform
select
patient
year
old
immunodepress
transplant
patient
patient
chronic
diseas
diabet
lung
kidney
cardiovascular
liver
neurolog
immunolog
oncolog
diseas
pregnant
women
notif
data
mitig
phase
patient
time
laps
symptom
onset
sampl
collect
day
avoid
misclassif
due
low
viral
load
sampl
collect
sampl
unavail
inform
hospit
sampl
unavail
laboratori
result
viru
sampl
store
outsid
nation
health
institut
doutor
ricardo
jorg
exclus
criteria
applic
hospit
patient
identifi
case
stratifi
two
group
hospit
influenza
posit
case
n
hospit
influenza
neg
case
n
sinc
risk
develop
influenza
vari
time
assur
select
control
group
similar
risk
develop
health
outcom
interest
case
group
hospit
case
nonhospit
control
match
week
onset
symptom
select
portugues
laboratori
network
databas
fig
hospit
use
measur
diseas
sever
context
defin
hospit
admiss
due
ili
complic
concomit
hospit
stay
twentyfour
hour
studi
protocol
approv
ethic
committe
nation
health
institut
doutor
ricardo
jorg
sinc
studi
use
irrevers
anonym
sampl
npi
obtain
inform
consent
particip
imposs
therefor
studi
author
ethic
committe
nation
health
institut
doutor
ricardo
jorg
without
inform
consent
particip
laboratori
diagnosi
virolog
character
nasopharyngealoropharyng
swab
collect
suitabl
transport
medium
preserv
viru
molecular
diagnost
viru
cultur
realtim
revers
transcriptas
pcr
methodolog
platform
use
laboratori
diagnosi
influenza
infect
addit
diagnos
viral
isol
antigen
genet
character
viral
isol
perform
accord
procedur
previous
describ
influenza
season
laboratori
network
carri
laboratori
diagnosi
influenza
infect
request
nation
health
servic
sampl
test
influenza
influenza
influenza
influenza
b
viru
genom
dna
extract
nasopharyngealoropharyng
swab
use
automat
system
magna
pure
lcroch
magna
pure
lc
total
nucleic
acid
isol
kit
snp
gene
genotyp
restrict
fragment
length
polymorph
rflp
use
follow
forward
revers
primer
tgagggttatggga
gatggggt
f
ggagaggagatggtgagggga
r
standard
pcr
condit
restrict
enzym
msci
use
cut
pcr
product
presenc
wild
type
allel
origin
fragment
visual
agaros
gel
statist
analysi
perform
use
r
program
pvalu
consid
statist
signific
ttest
wilcoxon
test
use
access
differ
quantit
variabl
accord
adher
normal
distribut
proport
compar
use
pearson
chisquar
test
regard
age
sex
nation
hospit
discharg
nhd
databas
use
assess
sampl
influenza
posit
hospit
case
analyz
present
studi
repres
total
influenza
intern
codif
diseas
code
hospit
patient
nh
period
time
exclud
patient
year
chronic
diseas
pregnant
women
allel
genotyp
frequenc
obtain
direct
count
test
hardyweinberg
equilibrium
use
hardi
weinberg
r
packag
perform
casecontrol
associ
analysi
hospit
patient
consid
case
nonhospit
patient
consid
control
analysi
stratifi
ili
posit
neg
patient
estim
adjust
oddsratio
use
condit
logist
regress
match
pair
data
includ
potenti
confound
effect
age
gender
variabl
patient
select
suffici
avail
frozen
swab
dna
extract
success
genotyp
sampl
ili
posit
patient
hospit
case
nonhospit
control
ili
neg
patient
hospit
case
nonhospit
control
correspond
overal
success
rate
ci
similar
group
patient
p
tabl
signific
differ
found
regard
age
p
sex
p
distribut
case
control
among
ili
posit
patient
ili
neg
patient
tabl
signific
differ
found
analys
influenza
posit
hospit
case
influenza
diagnos
hospit
patient
present
nhd
databas
regard
age
p
sex
p
tabl
concern
variant
character
tabl
patient
carri
cc
genotyp
detect
ili
posit
hospit
patient
ili
neg
nonhospit
patient
regard
infect
patient
ci
hospit
case
nonhospit
control
ct
genotyp
hospit
infect
case
c
allel
frequenc
ci
nonhospit
control
c
allel
frequenc
ci
neg
patient
hospit
case
ci
nonhospit
control
carri
ct
genotyp
hospit
case
c
allel
frequenc
ci
nonhospit
control
present
c
allel
frequenc
ci
tabl
assess
higher
risk
hospit
patient
carri
c
allel
presenc
absenc
viru
infect
perform
stratifi
analysi
assum
domin
model
present
tabl
presenc
viru
infect
observ
higher
risk
hospit
patient
ctcc
genotyp
compar
tt
genotyp
adjust
odd
ratio
ci
howev
use
approach
assess
higher
risk
hospit
c
allel
carrier
patient
neg
viru
infect
found
risk
hospit
among
ctcc
genotyp
carrier
significantli
higher
risk
hospit
tt
genotyp
carrier
adjust
odd
ratio
ci
order
measur
associ
variant
influenza
sever
infect
among
ili
patient
without
report
comorbl
design
specif
casecontrol
studi
pandem
scenario
result
show
variant
associ
respiratori
diseas
hospit
ili
patient
laboratori
confirm
influenza
infect
hand
observ
risk
hospit
ctcc
genotyp
fold
compar
tt
genotyp
ili
patient
neg
influenza
infect
given
result
hypothes
variant
involv
ili
symptom
sever
associ
respiratori
infect
pandem
influenza
season
portugues
laboratori
network
carri
influenza
viru
detect
influenza
influenza
season
influenza
influenza
b
viru
therefor
must
consid
hypothesi
presenc
infecti
agent
associ
respiratori
diseas
adenoviru
coronaviru
rhinoviru
respiratori
syncyti
viru
metapneumoviru
parainfluenza
viru
haemophilu
influenza
mycoplasma
pneumonia
streptococcu
pneumonia
less
frequent
respiratori
agent
influenza
neg
sampl
could
explain
result
addit
studi
show
also
import
mediat
viru
infect
west
nile
viru
dengu
viru
hypothesi
could
justifi
higher
percentag
c
allel
carrier
ili
hospit
influenza
neg
case
futur
detect
respiratori
viru
analyz
sampl
would
import
clarifi
result
compar
work
studi
previous
publish
everit
el
al
snp
regard
european
patient
found
similar
percentag
c
allel
carrier
among
influenza
hospit
posit
case
versu
howev
comparison
group
ili
non
hospit
influenza
posit
patient
mean
test
hypothesi
variant
involv
sever
influenza
infect
specif
compar
gener
popul
without
infect
european
genom
ili
hospit
influenza
posit
patient
evalu
infect
suscept
sever
without
abil
distinguish
effect
percentag
c
allel
carrier
ili
nonhospit
influenza
neg
control
closest
gener
popul
european
genom
expect
fig
result
must
interpret
take
account
limit
specif
studi
design
case
definit
hospit
use
measur
diseas
sever
might
consid
best
measur
pandem
scenario
given
less
sever
case
like
hospit
due
initi
pandem
alert
reduc
effect
risk
sever
hospit
howev
reduc
bia
exclud
patient
diseas
onset
report
content
phase
health
author
indic
hospitalis
influenza
case
addit
hospit
criteria
use
differ
health
unit
might
uniform
could
differ
influenza
posit
neg
case
given
pandem
alert
indic
health
author
differenti
criterion
hospit
could
explain
presenc
associ
neg
influenza
patient
absenc
posit
influenza
patient
extent
bia
could
evalu
avail
data
hand
perform
confound
adjust
age
sex
variabl
logist
regress
analysi
reduct
possibl
confound
bia
also
achiev
exclus
criteria
use
patient
select
exclud
patient
known
risk
factor
influenza
infect
complic
regard
possibl
select
bia
abl
evalu
repres
influenza
hospit
patient
less
year
age
without
known
co
morbid
patient
record
nhd
pandem
statist
differ
one
includ
studi
regard
age
sex
variabl
due
low
frequenc
observ
portugues
popul
also
european
popul
larg
number
case
would
need
better
defin
associ
popul
futur
import
perform
integr
approach
clarifi
healthi
individu
resist
infect
recov
quickli
other
experi
sever
diseas
associ
influenza
infect
could
done
consid
virushost
genom
interact
also
immun
vaccin
weather
condit
environment
factor
could
help
clarifi
present
result
moreov
earli
screen
host
genet
background
could
promis
strategi
identifi
potenti
therapeut
target
might
help
evalu
predict
sever
diseas
therebi
provid
critic
inform
decis
make
treatment
conclus
studi
show
variant
associ
hospit
risk
ili
hospit
influenza
neg
patient
howev
associ
found
ili
hospit
influenza
posit
case
confirm
variant
involv
ili
symptom
sever
associ
influenza
infect
absenc
effect
group
could
due
bia
associ
hospit
criteria
pandem
support
inform
also
includ
